In this article, we will look at stocks recently featured on Mad Money, as Jim Cramer analyzed the broader market impact of the recent AI data center rally. The host of CNBC’s Mad Money said on Wednesday that the market’s recent rebound is not living up to what investors typically look for in a lasting rally.

Whenever the market gets clobbered and then starts crawling back, you always hold out hope that there’ll be a broad advance, lots of different groups powering higher, easily accessible to the masses.

READ ALSO: 11 Stocks in Focus as Jim Cramer Discussed a Market Yearning for the Status Quo and Mad Money’s Latest Recap: Jim Cramer’s Strategy for Market Sell-Offs and 16 Stocks Mentioned.

Cramer pointed out that, two days into the current rebound, that kind of broad-based strength has yet to show up. Instead, he said the move so far appears narrow and modest, without a clear group of leading stocks to give investors confidence. He added that the rally “lacks any real leadership that you can hang your hat on, at least so far.”

Here’s the bottom line: This second-day rally isn’t necessarily a failure, but students of rallies know that the second day should be powerful with new leadership and a follow-through that’s broad, that lasts until 4:00 p.m. and doesn’t quit in early afternoon. That didn’t happen. This rally started losing steam around 1:30 p.m. Still a good day, but it could have been much, much stronger and much, much more powerful.

Our Methodology

For this article, we compiled a list of 11 stocks that were discussed by Jim Cramer during the episode of Mad Money aired on April 1. We listed the stocks in the order that Cramer mentioned them.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).

11 Stocks in Focus: Jim Cramer on NVIDIA, Callers’ Picks, and Recent AI Data Center Rally

11. Eli Lilly and Company (NYSE:LLY)

Eli Lilly and Company (NYSE:LLY) is among the stocks in focus, as Jim Cramer analyzed the broader market impact of the recent AI data center rally. Cramer highlighted the FDA approval of the company’s new weight loss pill and its acquisition of Centessa Pharmaceuticals, as he stated:

Today, we got big news from Eli Lilly. The Indianapolis colossus got approval for Foundayo, which is now the only GLP-1 weight loss pill that can be taken any time of day without food or water restrictions. It’s almost as strong as the injections. Starts at $25 per month of commercial coverage or between $149 and $349 per month if you’re paying out of pocket. When placed head-to-head against the competing pill from Novo Nordisk, I think Lilly’s got a winner… Ironically, though, the biggest news from Lilly may have been something that happened yesterday. That’s the acquisition of Centessa Pharmaceuticals, a biotech company, for $7.8 billion.

Centessa is trying to combat narcolepsy and other neurological disorders. They’re working on a neuropeptide called orexin, which is apparently something that people with narcolepsy are missing or don’t have a lot of. It’s possible that orexin can be used for much more than narcopsy… I like what Lilly’s doing here. It’s tackling some of the hardest to treat illnesses, ones that have often baffled and befuddled those drug companies that have attempted to beat mental illness. The path towards successful neurological treatment is littered with failures. The money that Lilly gets from its weight loss drug is being used wisely to come up with breakthrough drugs… Most importantly, though, let’s own the stock because I think this weight loss pill will be a blockbuster. And that’s why we’ve stuck with Eli Lilly for the Charitable Trust.

Eli Lilly and Company (NYSE:LLY) develops and markets medicines for diabetes, obesity, oncology, immunology, neuroscience, and other chronic conditions.

10. AECOM (NYSE:ACM)

AECOM (NYSE:ACM) is among the stocks in focus, as Jim Cramer analyzed the broader market impact of the recent AI data center rally. Toward the end of the lightning round, a caller inquired if they should add to their position, and here’s what Cramer had to say in response:

I think AECOM is a great company. I’m surprised to see it so low. People like Quanta and people like the letter J. AECOM, they think it’s too expensive, and there’s nothing I can do about it.

AECOM (NYSE:ACM) provides infrastructure consulting, design, and management services to public and private clients across the transportation, water, energy, and environmental sectors. During the March 6 episode, a caller asked whether the stock was a buy and if not, the caller inquired about good alternatives. The Mad Money host commented:

Yeah, they didn’t have a good quarter, and it’s a good company, but they did not have a good quarter. And if you’re going to be in that group, you want to be in a company… PWR okay, that’s the symbol. It’s called Quanta Services… It’s same business, better run.